Compared with non-viral-related HCC, the tumor immune microenvironment of HBV–HCC had a stronger immunosuppressive effect, which was reversed by PD-1 inhibitors (Liu et al., 2021). This evidence concerns the gene PDCD1 and hepatocellular carcinoma.